Earnings Feed
Start Free
Home/Filings/4/0001062993-24-010184
4//SEC Filing

Yanni Barbara 4

Accession 0001062993-24-010184

CIK 0001205922other
View on SEC.govCompany Profile

Filed

May 13, 8:00 PM ET

Accepted

May 14, 4:33 PM ET

Size

13.7 KB

Accession

0001062993-24-010184

Insider Transaction Report

Form 4
Period: 2024-05-10
VACCINEX, INC.VCNX
Yanni Barbara
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-05-10+10,108→ 10,108 total
    Exercise: $5.75From: 2025-05-10→ Common Stock (10,108 underlying)
Holdings

  • Stock Option (Right to Buy)

    Exercise: $86.10From: 2024-05-11→ Common Stock (684 underlying)
    684

  • Stock Option (Right to Buy)

    Exercise: $2856.00Exp: 2027-09-15→ Common Stock (30 underlying)
    30

  • Stock Option (Right to Buy)

    Exercise: $829.50From: 2021-05-14→ Common Stock (74 underlying)
    74

  • Stock Option (Right to Buy)

    Exercise: $235.20From: 2023-05-12→ Common Stock (253 underlying)
    253

  • Stock Option (Right to Buy)

    Exercise: $1633.80From: 2020-05-15→ Common Stock (36 underlying)
    36

  • Stock Option (Right to Buy)

    Exercise: $451.50From: 2022-05-11→ Common Stock (136 underlying)
    136
Footnotes (7)
  • [F1]Exercisable in full as of the date of this report.
  • [F2]This option expires on May 14, 2029 or five years following retirement or cessation of services, whichever occurs first.
  • [F3]This option expires on May 12, 2030 or five years following retirement or cessation of services, whichever occurs first.
  • [F4]This option expires on May 9, 2031 or five years following retirement or cessation of services, whichever occurs first.
  • [F5]This option expires on May 9, 2032 or five years following retirement or cessation of services, whichever occurs first.
  • [F6]This option expires on May 8, 2033 or five years following retirement or cessation of services, whichever occurs first.
  • [F7]This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 10, 2034 or five years following retirement or cessation of services, whichever occurs first.

Documents

1 file

Issuer

VACCINEX, INC.

CIK 0001205922

→
Entity typeother

Related Parties

1
  • filerCIK 0001610561

Filing Metadata

Form type
4
Filed
May 13, 8:00 PM ET
Accepted
May 14, 4:33 PM ET
Size
13.7 KB
View on SEC.gov